Allogene Therapeutics, Inc. Common Stock (ALLO) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ALLO. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 203 institutions reported holding ALLO, with 311.9 million shares worth $650.5 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 30,146,963 | $63M | INCREASED |
| Frazier Life Sciences Management, | 22,446,668 | $47M | INCREASED |
| Pfizer | 22,032,040 | $47M | UNCHANGED |
| State Street | 19,025,826 | $40M | INCREASED |
| Tpg GP a | 18,716,306 | $39M | UNCHANGED |
Full institutional holdings, insider history, and congressional trades for Allogene Therapeutics, Inc. Common Stock on SentiSense.